Mutant huntingtin represses CBP, but not p300, by binding and protein degradation

Shu-Yan Cong1, Barry A Pepers, Bernd O Evert

  • 1CBG-Center of Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.

Insights

Mutant huntingtin selectively degrades CBP, a key protein, impacting transcription and contributing to neurodegeneration in Huntington's disease models. This selective protein loss differs from other neurodegenerative conditions.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Huntington's disease (HD) serves as a model for protein aggregation-related neurodegenerative disorders.
  • Transcription factor sequestration in aggregates is a proposed pathogenic mechanism in HD.

Purpose of the Study:

  • To investigate the impact of mutant huntingtin on CBP and p300, crucial transcriptional coactivators.
  • To elucidate the mechanisms underlying CBP/p300 dysfunction in early and late stages of HD pathogenesis.

Main Methods:

  • Assessing transcriptional and histone acetyltransferase activity of CBP/p300.
  • Analyzing binding affinity of mutant huntingtin to CBP.
  • Investigating CBP protein degradation pathways.
  • Comparing CBP/p300 regulation in HD models versus spinocerebellar ataxia 3.

Main Results:

  • Soluble mutant huntingtin represses CBP transcriptional activity early on.
  • Histone acetyltransferase activity of CBP/p300 diminishes over time.
  • Mutant huntingtin exhibits stronger binding to CBP, leading to its repression.
  • CBP protein levels are reduced via proteasome degradation in later stages.
  • p300 remains unaffected, and selective CBP degradation is absent in spinocerebellar ataxia 3.

Conclusions:

  • Mutant huntingtin selectively targets CBP, not p300, through multiple mechanisms.
  • Altered CBP/p300 ratios and reduced CBP levels contribute to chromatin and transcriptional dysregulation in HD.
  • These molecular disruptions play a role in the neurodegenerative process of Huntington's disease.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Heterochromatin02:38

Heterochromatin

The extent of chromatin compaction can be studied by staining chromatin using specific DNA binding dyes. Under the microscope, the dense-compacted regions that take up more dye are called heterochromatin. Heterochromatin is further classified into two forms – constitutive heterochromatin and facultative heterochromatin.
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...